Stages:

• Early

 

Industries:

Life Sciences & Healthcare

 

Description:

Mission Bay Capital is an independent venture firm focused on making pivotal, early-stage investments in bioscience companies emerging from the University of California. Founded in June 2009, Mission Bay Capital is fueling breakthrough bioscience technologies to meet society's challenges while also helping to boost the California economy. Mission Bay Capital is managed by Douglas Crawford, PhD, who serves as the managing director of the fund in a pro-bono capacity, and is dedicated to promoting cross-disciplinary and cross-campus research within QB3 (see profile). The $7.5 million Mission Bay Capital Fund will be invested in companies whose founders or technologies are associated with the University of California system. In addition to bringing needed products and companies to fruition, MBC will return 20% of its profit to the University of California to populate subsequent MBC funds and provide an endowment for QB3. Limited partners in the fund include Pfizer Inc.; John Wadsworth, Jr., of Manitou Ventures; and law firm Wilson Sonsini Goodrich & Rosati Investments, among others.

 

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.